These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 15340100)
1. Current and investigational antiobesity agents and obesity therapeutic treatment targets. Bays HE Obes Res; 2004 Aug; 12(8):1197-211. PubMed ID: 15340100 [TBL] [Abstract][Full Text] [Related]
2. Investigational therapies in the treatment of obesity. Mancini MC; Halpern A Expert Opin Investig Drugs; 2006 Aug; 15(8):897-915. PubMed ID: 16859393 [TBL] [Abstract][Full Text] [Related]
3. [Obesity: a review of currently used antiobesity drugs and new compounds in clinical development]. Zieba R Postepy Hig Med Dosw (Online); 2007 Oct; 61():612-26. PubMed ID: 17971763 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of (ant)-agonists that alter appetite and adiposity. Van der Ploeg LH; Kanatani A; MacNeil D; Ming Fong T; Strack A; Nargund R; Guan XM Prog Brain Res; 2006; 153():107-18. PubMed ID: 16876570 [TBL] [Abstract][Full Text] [Related]
13. Obesity Drug Development Summit. 21-22 July, 2005, Arlington, VA, USA. Maggio CA IDrugs; 2005 Sep; 8(9):701-3. PubMed ID: 16118685 [TBL] [Abstract][Full Text] [Related]
14. Plasma and hypothalamic peptide-hormone levels regulating somatotroph function and energy balance in fed and fasted states: a comparative study in four strains of rats. Kappeler L; Zizzari P; Grouselle D; Epelbaum J; Bluet-Pajot MT J Neuroendocrinol; 2004 Dec; 16(12):980-8. PubMed ID: 15667453 [TBL] [Abstract][Full Text] [Related]
15. Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients? Bays H; Blonde L; Rosenson R Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):871-95. PubMed ID: 17173503 [TBL] [Abstract][Full Text] [Related]
16. Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors. Jensen MD Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():143S-149S. PubMed ID: 16931496 [TBL] [Abstract][Full Text] [Related]
17. Newly approved and promising antidiabetic agents. Combettes M; Kargar C Therapie; 2007; 62(4):293-310. PubMed ID: 17983555 [TBL] [Abstract][Full Text] [Related]
18. [Molecular targets for new drug discovery to treat type 2 diabetes and obesity]. Bastarrachea RA; Montero JC; Saavedra-Gajardo I; Cerda-Flores R; Machado-DomÃnguez A; Comuzzie AG Rev Med Chil; 2008 Jan; 136(1):107-17. PubMed ID: 18483661 [TBL] [Abstract][Full Text] [Related]
19. Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon. Srivastava G; Apovian C Curr Obes Rep; 2018 Jun; 7(2):147-161. PubMed ID: 29504049 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus. Koren S; Fantus IG Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):621-40. PubMed ID: 18054739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]